BPIFB1
Basic information
Region (hg38): 20:33273480-33309871
Previous symbols: [ "C20orf114" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BPIFB1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 20 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 20 | 3 | 4 |
Variants in BPIFB1
This is a list of pathogenic ClinVar variants found in the BPIFB1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-33286085-G-A | Benign (Apr 26, 2018) | |||
20-33286167-G-C | not specified | Uncertain significance (Nov 18, 2022) | ||
20-33286179-A-G | not specified | Uncertain significance (Dec 17, 2023) | ||
20-33288741-A-G | Benign (Jun 29, 2018) | |||
20-33288768-A-G | not specified | Uncertain significance (Sep 23, 2023) | ||
20-33288795-C-T | not specified | Uncertain significance (Dec 06, 2023) | ||
20-33288806-G-T | not specified | Uncertain significance (Nov 09, 2021) | ||
20-33288807-C-A | not specified | Uncertain significance (Nov 09, 2021) | ||
20-33288812-C-T | not specified | Uncertain significance (Jul 11, 2023) | ||
20-33288863-G-A | not specified | Likely benign (Jun 14, 2023) | ||
20-33289964-C-T | Benign (Aug 15, 2017) | |||
20-33290977-T-C | not specified | Uncertain significance (Aug 08, 2022) | ||
20-33291009-A-G | Benign (Feb 26, 2018) | |||
20-33291057-A-T | not specified | Uncertain significance (Apr 20, 2024) | ||
20-33297534-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
20-33299935-A-T | not specified | Uncertain significance (Feb 07, 2023) | ||
20-33301303-C-G | not specified | Uncertain significance (Sep 30, 2022) | ||
20-33301306-C-T | not specified | Uncertain significance (Dec 09, 2023) | ||
20-33301350-G-A | not specified | Uncertain significance (Oct 26, 2021) | ||
20-33302371-G-T | not specified | Uncertain significance (Oct 10, 2023) | ||
20-33302378-G-A | not specified | Likely benign (Jul 12, 2023) | ||
20-33302916-G-C | not specified | Uncertain significance (Dec 03, 2021) | ||
20-33303977-A-T | not specified | Uncertain significance (Jan 16, 2024) | ||
20-33304018-A-C | not specified | Uncertain significance (Apr 19, 2023) | ||
20-33304854-G-A | not specified | Uncertain significance (Apr 08, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BPIFB1 | protein_coding | protein_coding | ENST00000253354 | 15 | 36399 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.32e-8 | 0.895 | 125675 | 0 | 73 | 125748 | 0.000290 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.630 | 245 | 274 | 0.893 | 0.0000148 | 3124 |
Missense in Polyphen | 56 | 64.432 | 0.86913 | 787 | ||
Synonymous | 0.541 | 112 | 120 | 0.937 | 0.00000693 | 1017 |
Loss of Function | 1.73 | 16 | 25.4 | 0.630 | 0.00000125 | 278 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000716 | 0.000716 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000489 | 0.000489 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000317 | 0.000316 |
Middle Eastern | 0.000489 | 0.000489 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in innate immunity in mouth, nose and lungs. Binds bacterial lipopolysaccharide (LPS) and modulates the cellular responses to LPS. {ECO:0000269|PubMed:21900486}.;
- Pathway
- Antimicrobial peptides;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.0906
Intolerance Scores
- loftool
- rvis_EVS
- 1.49
- rvis_percentile_EVS
- 95.36
Haploinsufficiency Scores
- pHI
- 0.0627
- hipred
- N
- hipred_score
- 0.173
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bpifb1
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype;
Gene ontology
- Biological process
- innate immune response in mucosa;antimicrobial humoral response;negative regulation of toll-like receptor 4 signaling pathway
- Cellular component
- extracellular region;extracellular exosome
- Molecular function
- molecular_function;lipid binding